1. We forecast Amazon's stock to drop to $155 within nine months due to a completed long-term Elliott Wave pattern; 2. Investor sentiment is overly bullish and at a level that has historically preceded corrections; 3. Bollinger Bands indicate intermediate support for AMZN at $155, aligning with our price target.

1. Lockheed Martin is benefiting from the current geopolitical environment; 2. The company shows strong technical and fundamental performance; 3. The article justifies a buy rating despite high valuation multiples.

1. Exxon Mobil has broken out of a two-year trading range due to rising oil prices; 2. The company's fair value is estimated at $140 per share; 3. Risks include potential declines in oil prices and higher-than-expected capital expenditures.

1. Costco is experiencing a pullback post-earnings, triggering a buy on weakness signal; 2. Long-term charts show consistent pullbacks in COST, an uptrend stock outperforming the market; 3. Despite weak growth and valuation, strong profitability, momentum, and revisions suggest a bounce to new highs.

1. AMD is poised for a potential breakout from its current trading range due to strong Q2 earnings and robust Data Center revenue growth; 2. The acquisition of ZT Systems enhances AMD's AI and data center capabilities, potentially boosting revenue and market position; 3. Risks include failing to break resistance at $160 and negative analyst sentiment regarding the ZT Systems acquisition or data center guidance.

1. Correctly identified Micron Technology's short-term Sell signal and long-term Buy signal; 2. Recent earnings confirm the long-term Buy outlook; 3. Weekly chart shows a switch from a Sell to a Buy signal, with a bullish double bottom formation; 4. Short-term price drop due to day traders filling the gap from panic buying, but no expectation of retesting the bottom; 5. Company on Model Portfolio Watchlist with a low SID score, anticipating a 32% move up.

1. Despite Warren Buffett's investment, Occidental Petroleum's technical outlook is bearish across all time frames; 2. OXY lacks significant support and is overvalued relative to its historical growth figures; 3. Daily, weekly, and monthly analyses all confirm a downtrend with no signs of reversal, indicating further downside is likely.

1. AMD's stock has significantly declined, with technical analysis indicating a very weak outlook across daily, weekly, and monthly charts, showing strong sell signals. 2. Short-term and intermediate-term analyses show negative indicators, including a death cross in moving averages and bearish crossovers in stochastics and MACD. 3. Despite some long-term support, the monthly analysis reveals significant downside risks, with bearish SMA crossovers and negative MACD and stochastics signals. Overall, AMD is rated a strong sell due to converging technical indicators suggesting major decline potential in the short and intermediate terms.

1. Tesla is breaking out of a summer trading range, approaching a critical $260 resistance level; 2. Tesla's operational advantages, including EV production capacity and FSD technology, position it well against competitors; 3. Revenue growth is expected to accelerate in 2025 and 2026, despite low single-digit growth in 2024.

1. Despite the recent surge in gold, the probability of a sustained pullback to $2,300 has increased due to technical developments in related macro markets. 2. The USD and bond yields are trading at key support levels, with the market aggressively pricing in rate cuts. 3. Cyclical commodity sectors like energy, base metals, and agriculture show potential for outperformance, suggesting disinflation fears may be overdone.

1. The author has warned about the risks of owning Direxion Daily Semiconductor Bull 3x Shares ETF (SOXL) since April. 2. SOXL has dropped 25% since the original article, with a potential for another 50% to 80% loss. 3. The daily rebalancing feature and high holding costs make long-term gains unlikely.

1. Merck's 15% decline in July presents an intermediate to long-term buying opportunity for investors. 2. Long-term trend lines and Bollinger Bands suggest strong support at $110, with an expected return to July's high of $133. 3. Sentiment indicators show a majority of investors expect lower prices, which is a positive sign for higher prices. 4. RSI levels indicate Merck is oversold for the intermediate term, suggesting a significant rally. 5. If the price target of $133 is reached, the article will reassess whether it's forming a double top or going higher.

1. Amazon's revenue growth remains steady, with a positive outlook for AWS offset by slower e-commerce growth due to a weaker consumer environment. 2. Despite a rare EBIT margin guidance disappointment, potential easing of global container freight rates and internal cost-saving initiatives offer margin expansion opportunities. 3. The stock's technical pullback creates a favorable entry point for investors, suggesting a potential for multiple expansion and outperformance.

1. The S&P 500 has declined for three consecutive weeks, nearing the 5265 target. 2. Technical analysis suggests a potential collapse, but the author is prepared to bet against it under favorable conditions. 3. The article provides a detailed technical outlook and conditions for potential buying opportunities.

1. Pfizer's stock is trading above its 30-week EMA, indicating a bullish trend. 2. The company has shown increasing momentum and improving relative strength. 3. Smart money buying and volume spikes suggest a bullish outlook for Pfizer stock.